Eris Lifesciences Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Eris Lifesciences Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
ERIS

Click to see a quick summary and important updates about this stock!Dismiss

Eris Lifesciences Ltd.

BSE: 540596, NSE: ERIS

  • Market Capitalisation info

    ₹9,092 Cr


  • 12 Month Earnings info

    ₹396 Cr

  • Price to Earnings info

    22.93

₹669.60

As on 25-Nov-2022 IST

up-down-arrow3.100.47%

  • Prev Close info

    666.50

  • Day's Openinfo

    669.80

  • Today's Highinfo

    677.00

  • Today's Lowinfo

    661.55

  • Today's Volumeinfo

    53,273

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Eris Lifesciences
-11.90 -8.96 -0.72 -8.90 17.33 1.05 --
S&P BSE Healthcare
-9.68 0.70 3.71 -5.12 20.88 10.98 11.88
S&P BSE Mid Cap
2.51 2.67 2.51 0.37 20.20 8.61 14.52
As on 25-Nov-2022
2021
2020
2019
2018
Eris Lifesciences
28.80 16.83 -31.52 -12.34
S&P BSE Mid Cap
39.18 19.87 -3.05 -13.31
S&P BSE Healthcare
20.87 61.45 -3.55 -5.89

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        Other Details

        Incorporated

        2007

        Chairman

        Amit Indubhushan Bakshi

        Managing Director

        Amit Indubhushan Bakshi

        Headquarters

        Ahmedabad, Gujarat
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹9,092.34 Cr

        • Revenue (TTM) info

          ₹1,497.20 Cr

        • Earnings (TTM) info

          ₹395.94 Cr

        • Cash info

          ₹70.08 Cr

        • Total Debt info

          ₹45.01 Cr

        • Promoters' ownership info

          52.29%

        • Liquidity info

          High

        • 52 Week range info

          ₹600.30 - 774.00

        • Face value info

          ₹1.00

        • Shares outstanding info

          13,59,90,717

        • 10 Years Aggregate:

          CFO: ₹2,031.81 Cr

          EBITDA: ₹2,698.05 Cr

          Net Profit: ₹2,243.63 Cr

        About The Company

        • Business

          Manufacture of pharmaceuticals, medicinal chemical and botanical products

        • Incorporated

          2007

        • Chairman

          Amit Indubhushan Bakshi

        • Managing Director

          Amit Indubhushan Bakshi

        • Listing info

          BSE: 540596, NSE: ERIS

        • Country

          India

        • Headquarters info

          Ahmedabad, Gujarat

        • Website info

          www.eris.co.in